Parallax Volatility Advisers, L.P. United Therapeutics Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $4.57 Million - $6.38 Million	20,000 New	20,000 $6.37 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $21.6 Million - $29.5 Million	-105,100 Reduced 83.88%	20,200 $5.62 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $25.5 Million - $30.6 Million	125,300 New	125,300 $26.2 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $4.76 Million - $7.56 Million	62,600 Added 2845.45%	64,800 $5.06 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $4.06 Million - $5.15 Million	-40,000 Reduced 94.79%	2,200 $240,000
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $4.8 Million - $5.46 Million	42,200 New	42,200 $5.4 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.